| Trial ID: | L1347 |
| Source ID: | NCT00157651
|
| Associated Drug: |
Warfarin
|
| Title: |
Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Thrombosis|Bleeding
|
| Interventions: |
DRUG: warfarin|DRUG: placebo
|
| Outcome Measures: |
Primary: Time from catheter insertion to mechanical failure. This is defined as inability to aspirate or persistent blood flow less than 200mL/min after line reversal, patient repositioning and rotational manipulation of the catheter., monthly | Secondary: Blood flow rate and adequacy of dialysis., monthly|Major bleeding events., monthly|Death from any cause., monthly
|
| Sponsor/Collaborators: |
Sponsor: Hamilton Health Sciences Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
170
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
1999-02
|
| Completion Date: |
2007-03
|
| Results First Posted: |
|
| Last Update Posted: |
2008-06-17
|
| Locations: |
St. Joseph's Healthcare, Hamilton, Ontario, L8N 4A6, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00157651
|
